Gender-related drug effect on several markers of oxidation stress in diabetes patients with and without complications

European Journal of Pharmacology

Volumn 766, Issue , 2015, Pages 86-90

  Lodovici, Maura ^a   Bigagli, Elisabetta ^a   Luceri, Cristina ^a   Mannucci, Edoardo ^b   Rotella, Carlo Maria ^c   Raimondi, Laura ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Careggi Teaching Hospital   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Gender; Hs CRP; Metformin; Oxidation stress; Statins; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; CARBONYL DERIVATIVE; COPPER ZINC SUPEROXIDE DISMUTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; METFORMIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES CONTROL; DRUG EFFICACY; FEMALE; FERRIC REDUCING ABILITY OF PLASMA; HEART PROTECTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK REDUCTION; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; DIABETES MELLITUS; MIDDLE AGED;

AGED; BIOMARKERS; C-REACTIVE PROTEIN; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SEX FACTORS; SUPEROXIDE DISMUTASE;

EID: 84945979684     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.09.041     Document Type: Article

References (27)

1. A.A. Abdulkadir, and I.A. Thanoon Comparative effects of glibenclamide and metformin on C-reactive protein and oxidant/antioxidant status in patients with type II diabetes mellitus Sultan Qaboos Univ. Med. J. 12 2012 55 61
2. C. Beauchamp, and I. Fridovich Superoxide dismutase: improved assays and an assay applicable to acrylamide gels Anal. Biochem. 44 1971 276 287
3. I.F. Benzie, and J.J. Strain The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay Anal. Biochem. 239 1996 70 76
4. E. Bigagli, L. Raimondi, E. Mannucci, G. Colombi, G. Bardini, C.M. Rotella, and M. Lodovici Lipid and protein oxidation products, antioxidant status and vascular complications in poorly controlled type 2 diabetes Br. J. Diabetes Vasc. Dis. 12 2011 33 39
5. S. Blum, M. Vardi, N.S. Levy, R. Miller-Lotan, and A.P. Levy The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes Atherosclerosis 211 2010 25 27
6. V. Correa-Salde, and I. Albesa Reactive oxidant species and oxidation of protein and haemoglobin as biomarkers of susceptibility to stress caused by chloramphenicol Biomed. Pharmacother. 63 2009 100 104
7. L.G. De Aguiar, L.R. Bahia, N. Villela, C. Laflor, F. Sicuro, N. Wiernsperger, D. Bottino, and E. Bouskela Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance Diabetes Care 29 2006 1083 1095
8. F.M. De Vries, J. Kolthof, M.J. Postma, M.J. Denig, and P. Hak, E. Efficacy of standard and intensive statin treatment for the secondary prevention of cardiovascular and cerebrovascular events in diabetes patients: a meta-analysis PLoS One 9 2014 e111247
9. ESHRE Capri Workshop Group Hormones and cardiovascular health in women Hum. Reprod. Update 12 2006 483 497
10. J.E. Hokanson, and M.A. Austin Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies J. Cardiovasc. Risk 3 1996 213 219
11. F. Jabeen, A. Fawwad, H.A. Rizvi, and F. Alvi Role of platelet indices, glycemic control and hs-CRP in pathogenesis of vascular complications in type-2 diabetic patients Pak. J. Med. Sci. 29 2013 152 156
12. A.P. Levy, H.C. Gerstein, R. Miller-Lotan, R. Ratner, L.E. McQueenM, and J. Pogue The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different heptoglobin phenotypes Diabetes Care 27 2004 276 277
13. V. Lubrano, F. Cocci, D. Battaglia, A. Papa, P. Marraccini, and G.C. Zucchelli Usefulness of high-sensitivity IL-6 measurement for clinical characterization of patients with coronary artery disease J. Clin. Lab. Anal. 19 2005 110 114
14. V. Manfredini, G.B. Biancini, C.S. Vanzin, A.M. Dal Vesco, F. Cipriani, L. Biasi, R. Treméa, M. Deon, C. Peralba, Mdo, M. Wajner, and C.R. Vargas Simvastatin treatment prevents oxidative damage to DNA in whole blood leukocytes of dyslipidemic type 2 diabetic patients Cell Biochem. Funct. 28 2010 360 366
15. R. Mateos, L. Goya, and L. Bravo Determination of malondialdehyde by liquid chromatography as the 2,4-dinitrophenylhydrazone derivative: a marker for oxidative stress in cell cultures of human hepatoma HepG2 J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 805 2004 33 39
16. F. Piarulli, G. Sartore, A. Ceriello, E. Ragazzi, R. Reitano, L. Nollino, C. Cosma, D. Fedele, and A. Lapolla Relationship between glyco-oxidation, antioxidant status and microalbuminuria in type 2 diabetic patients Diabetologia 52 2009 1419 1425
17. F. Piarulli, G. Sartore, and A. Lapolla Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update Acta Diabetol. 50 2013 101 110
18. A.D. Pradhan, B.M. Everett, N.R. Cook, N. Rifai, and P.M. Ridker Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial JAMA 302 2009 1186 1194
19. C. Rask-Madsen, and G.L. King Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes Natl. Clinl. Pract. Endocrinol. Metab. 3 2007 46 56
20. R.P. Robertson, and J.S. Harmon Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell Free Radic. Biol. Med. 41 2006 177 184
21. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, R.D. Jackson, S.A. Beresford, B.V. Howard, K.C. Johnson, J.M. Kotchen, and J. l Ockene Risks and benefits of estro-gen plus progestin in healthy postmenopausal women: principal results from the women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
22. N. Sarwar, P. Gao, S.R. Seshasai, R. Gobin, S. Kaptoge, E. Di Angelantonio, E. Ingelsson, D.A. Lawlor, E. Selvin, M. Stampfer, C.D. Stehouwer, S. Lewington, L. Pennells, A. Thompson, N. Sattar, I.R. White, K.K. Ray, J. Danesh, and Emerging Risk Factors Collaboration Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies Lancet 375 2010 2215 2222
23. T. Sathyapalan, J. Shepherd, S.L. Atkin, and E.S. Kilpatrick The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes: a crossover study Diabetes Obes. Metab. 15 2013 767 769
24. R.J. Stern, E.J. Murphy, and D. Phil Metformin as initial oral therapy in type 2 diabetes JAMA 313 2015 2484 2485
25. O. Tabak, R. Gelisgen, H. Erman, F. Erdenen, C. Muderrisoglu, H. Aral, and H. Uzun Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus Clin. Investig. Med. 34 2011 E163 E171
26. C. Vitale, G. Mercuro, A. Cornoldi, M. Fini, M. Volterrani, and G.M. Rosano Metformin improves endothelial function in patients with metabolic syndrome J. Int. Med. 258 2005 250 256
27. M. Wang, M. Crager, and S. Pugazhenthi Modulation of apoptosis pathways by oxidative stress and autophagy in β cells Exp. Diabetes Res. 2012 2012 1 14